Harnovi kills hepatitis C only in 8 weeks

Published: 2018-05-31 16:30:00
Updated: 2018-05-31 17:06:42

Gilead Sciences’ hepatitis C treatment Harvoni(generic name: ledipasvir/sofosbuvir) have shown excellent efficacy only with a 8-week therapy, not 12 weeks.

Gilead Sciences Korea held a press conference to celebrate expanded health insurance benefits for Harvoni at The Westin Chosun Seoul on the ...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.